MUCIN-MEDIATED IMMUNOMODULATION - Patent 0964694

(19)

(11)

EP 0 964 694 A1

(12)

(43)	Date of publication:
	22.12.1999 Bulletin 1999/51

(21)	Application number: 97946409.0

(22)	Date of filing: 24.10.1997

(51)

International Patent Classification (IPC):

A01K 67/ 027^{( . )}
A61K 35/ 26^{( . )}
A61K 38/ 00^{( . )}
A61K 39/ 395^{( . )}
A61P 35/ 00^{( . )}
A61P 37/ 06^{( . )}
C07K 16/ 18^{( . )}
C12N 15/ 09^{( . )}

A61K 31/ 711^{( . )}
A61K 35/ 37^{( . )}
A61K 38/ 17^{( . )}
A61K 48/ 00^{( . )}
A61P 37/ 04^{( . )}
C07K 14/ 47^{( . )}
C12N 5/ 10^{( . )}

(86)	International application number:
	PCT/US1997/019784

(87)	International publication number:
	WO 1998/017300 (30.04.1998 Gazette 1998/17)

(84)	Designated Contracting States:
	CH DE GB LI

(30)

Priority:

25.10.1996 US 19960738262

(71)	Applicant: DANA-FARBER CANCER INSTITUTE, INC.
	Boston, MA 02115 (US)

(72)	Inventors:
	GONG, Jianlin Brookline, MA 02146 (US) KUFE, Donald Wellesley, MA 02181 (US)

(74)	Representative: Dzieglewska, Hanna Eva
	Frank B. Dehn & Co., European Patent Attorneys, 179 Queen Victoria Street London EC4V 4EL London EC4V 4EL (GB)

(54)	MUCIN-MEDIATED IMMUNOMODULATION